(2016) Artificial Blood Substitutes: First Steps on the Long Route to Clinical Utility. Clinical Medicine Insights-Blood Disorders. pp. 33-41. ISSN 1179-545X
Full text not available from this repository.
Abstract
The 21st century is challenging for human beings. Increased population growth, population aging, generation of new infectious agents, and natural disasters are some threatening factors for the current state of blood transfusion. However, it seems that science and technology not only could overcome these challenges but also would turn many human dreams to reality in this regard. Scientists believe that one of the future evolutionary innovations could be artificial blood substitutes that might pave the way to a new era in transfusion medicine. In this review, recent status and progresses in artificial blood substitutes, focusing on red blood cells substitutes, are summarized. In addition, steps taken toward the development of artificial blood technology and some of their promises and hurdles will be highlighted. However, it must be noted that artificial blood is still at the preliminary stages of development, and to fulfill this dream, ie, to routinely transfuse artificial blood into human vessels, we still have to strengthen our knowledge and be patient.
Item Type: | Article |
---|---|
Keywords: | artificial blood oxygen carrier hemoglobin red blood cells polymersome encapsulated hemoglobin oxygen carriers recombinant hemoglobin transfusion medicine escherichia-coli cell substitutes nanoparticles circulation generation expression |
Page Range: | pp. 33-41 |
Journal or Publication Title: | Clinical Medicine Insights-Blood Disorders |
Journal Index: | ISI |
Volume: | 9 |
Identification Number: | https://doi.org/10.4137/Cmbd.S38461 |
ISSN: | 1179-545X |
Depositing User: | مهندس مهدی شریفی |
URI: | http://eprints.mui.ac.ir/id/eprint/2994 |
Actions (login required)
View Item |